Kutok Jeffery
Chief Scientific Officer at Epizyme, Inc.; Chief Scientific Officer at INFINITY PHARMACEUTICALS, INC.
- Sold, on record
- $81k
- Dollars the filings state
- Form 4 sales
- 5
- Latest Apr 11, 2022
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Epizyme, Inc.Chief Scientific Officer
- INFINITY PHARMACEUTICALS, INC.Chief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- INFINITY PHARMACEUTICALS, INC.28,626 shares
- Epizyme, Inc.7,326 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale INFINITY PHARMACEUTICALS, INC.UnusualJun 22, 2018 2018
Sold 14,313 shares at $2.00 ($29k)
Kutok Jeffery, Chief Scientific Officer
Sold 50% of holdings ($57k position)14,313 shares leftFirst sale on recordFiling
- 2 Form 4 sale INFINITY PHARMACEUTICALS, INC.UnusualAug 16, 2018 +55 days
Sold 14,313 shares at $2.01 ($29k)
Kutok Jeffery, Chief Scientific Officer
Sold 100% of holdings ($29k position)0 shares leftFiling
- 3 Form 4 sale Epizyme, Inc.Plan not statedApr 5, 2021 +963 days
Sold 2,029 shares at $8.80 ($18k)
Kutok Jeffery, Chief Scientific Officer
Sold 3.6% of holdings ($493k position)54,028 shares leftFirst sale on recordFiling
- 4 Form 4 sale Epizyme, Inc.Plan not statedFeb 2, 2022 +303 days
Sold 2,556 shares at $1.37 ($4k)
Kutok Jeffery, Chief Scientific Officer
Sold 2.6% of holdings ($137k position)97,304 shares leftFiling
- 5 Form 4 sale Epizyme, Inc.Plan not statedApr 11, 2022 +68 days
Sold 2,741 shares at $0.90 ($2k)
Kutok Jeffery, Chief Scientific Officer
Sold 2.8% of holdings ($88k position)94,563 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Apr 11, 2022 | Apr 13, 2022 | Epizyme, Inc. | Chief Scientific Officer | Form 4 sale | 2,741 | $2k | 2.8% | Plan not stated | SEC |
| Feb 2, 2022 | Feb 4, 2022 | Epizyme, Inc. | Chief Scientific Officer | Form 4 sale | 2,556 | $4k | 2.6% | Plan not stated | SEC |
| Apr 5, 2021 | Apr 7, 2021 | Epizyme, Inc. | Chief Scientific Officer | Form 4 sale | 2,029 | $18k | 3.6% | Plan not stated | SEC |
| Aug 16, 2018 | Aug 17, 2018 | INFINITY PHARMACEUTICALS, INC. | Chief Scientific Officer | Form 4 sale | 14,313 | $29k | 100.0% | Unusual | SEC |
| Jun 22, 2018 | Jun 25, 2018 | INFINITY PHARMACEUTICALS, INC. | Chief Scientific Officer | Form 4 sale | 14,313 | $29k | 50.0% | Unusual | SEC |